{"disease":{"id":"treatment-of-superficial-bladder-cancer-stage-ta-t1-tis-high-grade-high-risk-carcinoma-in-situ-high-grade-tumor-high-risk-tumor-non-muscle-invasive-non-muscle-invasive-bladder-cancer-non-muscle-invasive-bladder-cancer-nmibc-non-muscle-invasive-bladder-cancer-nmibc-with-carcinoma-in-situ-non-muscle-invasive-bladder-cancer-nmibc-with-high-grade-tumor-non-muscle-invasive-bladder-cancer-nmibc-with-high-risk-tumor-non-muscle-invasive-bladder-cancer-nmibc-with-high-risk-tumor.md","name":"treatment of superficial bladder cancer stage ta t1 tis high grade high risk carcinoma in situ high grade tumor high risk tumor non muscle invasive non muscle invasive bladder cancer non muscle invasive bladder cancer nmibc non muscle invasive bladder cancer nmibc with carcinoma in situ non muscle invasive bladder cancer nmibc with high grade tumor non muscle invasive bladder cancer nmibc with high risk tumor non muscle invasive bladder cancer nmibc with high risk tumor.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}